Related Experiment Video
Updated: Aug 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The diabetic patient with hypertension
G P Leese1, M W Savage, P D Chattington
1Ninewells Hospital, Dundee, UK.
Insights
Managing hypertension in diabetic patients is crucial for slowing kidney function decline and reducing cardiovascular risks. Aggressive blood pressure control is recommended, with specific drug classes offering additional benefits for kidney and metabolic health.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Hypertension and diabetes frequently coexist, increasing cardiovascular and renal risks.
- Diabetic renal disease, detectable by microalbuminuria, is a common complication.
- Ambulatory blood pressure monitoring can reveal nocturnal dipping loss, missed by standard measures.
Purpose of the Study:
- To review the management of hypertension in patients with diabetes.
- To highlight the importance of aggressive blood pressure control in preserving renal function.
- To discuss the cardiovascular and metabolic effects of various antihypertensive drugs.
Main Methods:
- Review of current literature on hypertension and diabetes management.
- Analysis of cardiovascular events and renal function in relation to blood pressure.
- Evaluation of antihypertensive drug classes and their impact on metabolic parameters and left ventricular hypertrophy.
Main Results:
- Aggressive hypertension treatment is vital for slowing glomerular filtration rate decline.
- No 'J'-shaped curve observed for blood pressure and cardiovascular events in diabetics, supporting lower targets.
- Angiotensin-converting enzyme inhibitors offer renoprotective benefits.
- Non-dihydropyridine calcium antagonists are preferred over dihydropyridines due to potential proteinuria augmentation.
- Alpha-adrenergic antagonists may improve lipid profiles; beta-blockers and thiazide diuretics can negatively impact glycemic and lipid profiles.
Conclusions:
- Effective hypertension management is essential for reducing morbidity and mortality in diabetic patients.
- Drug selection should consider effects on renal function, cardiovascular health, and metabolic parameters.
- ACE inhibitors and non-dihydropyridine calcium antagonists are favorable choices, while beta-blockers and thiazides require careful consideration.
Abstract:
Hypertension and diabetes co-exist more commonly than would be expected from their individual prevalences. Elevated blood pressure is most commonly due to coexisting essential hypertension, or diabetic renal disease. Early stages of diabetic renal disease can be identified by detecting microalbuminuria. Standard measures of blood pressure are not necessarily raised, but 24-hour ambulatory measures frequently identify a loss of nocturnal drop in blood pressure. Treating hypertension aggressively is important in slowing the inexorable decline in glomerular filtration rate. In diabetes there appears to be no 'J'-shaped relationship between blood pressure and cardiovascular events, thus removing any concern about attaining low blood pressures as long as the patient is asymptomatic. Morbidity and mortality in these patients is usually associated with cardiovascular events, and it is important to assess the effect of drugs on left ventricular hypertrophy and metabolic parameters. Many drugs are effective at lowering blood pressure, but angiotensin-converting enzyme inhibitors may have an additional renoprotective action. alpha-Adrenergic antagonists may improve lipid profiles and calcium antagonists are probably lipid neutral, making these drugs useful alternatives. Dihydropyridine calcium antagonists (eg, nifedipine) may augment protein-uria, and hence non-dihydropyridine calcium antagonists (eg, verapamil, diltiazem) would be preferred. beta-Blockers and thiazide diuretics have the disadvantage of causing a deterioration in glycaemic and lipid profiles, but can be useful on occasions.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hyperglycemia
Diabetic Retinopathy
Diabetic Nephropathy

